Medicinova (MNOV) Non-Current Assets (2010 - 2025)
Medicinova's (MNOV) quarterly Non-Current Assets came in at $14.6 million in Q4 2025, down 1.28% year-on-year from $14.8 million in Q4 2024, and little changed on a QoQ basis from $14.7 million in Q3 2025.
Medicinova (MNOV) Non-Current Assets (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Non-Current Assets data on file, last reported at $14.6 million in Q4 2025.
- On a quarterly basis, Non-Current Assets fell 1.28% year-over-year to $14.6 million in Q4 2025; TTM through Dec 2025 was $58.7 million, a 1.45% decrease from a year earlier, with the FY2025 full-year figure at $14.6 million, down 1.28% from the prior year.
- Non-Current Assets for Q4 2025 stood at $14.6 million, roughly flat from $14.7 million in the prior quarter.
- Over the last five years, Non-Current Assets for MNOV reached as high as $25.2 million in Q3 2022 and fell as low as $14.6 million in Q4 2025.
- Historically, Non-Current Assets has averaged $15.5 million across 5 years, with a median of $15.1 million in 2023.
- Across the five-year window, Non-Current Assets surged 63.24% in 2022 and slumped 40.02% in 2023, its largest moves.
- Year by year, Non-Current Assets stood at $15.4 million in 2021, then dropped by 1.49% to $15.2 million in 2022, then decreased by 0.48% to $15.1 million in 2023, then decreased by 1.95% to $14.8 million in 2024, then slipped by 1.28% to $14.6 million in 2025.
- Per Business Quant data, the three most recent Non-Current Assets figures were $14.6 million in Q4 2025, $14.7 million in Q3 2025, and $14.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | 14.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.61 Mn |
| Sep 30, 2025 | 14.66 Mn |
| Jun 30, 2025 | 14.70 Mn |
| Mar 31, 2025 | 14.75 Mn |
| Dec 31, 2024 | 14.80 Mn |
| Sep 30, 2024 | 14.85 Mn |
| Jun 30, 2024 | 14.90 Mn |
| Mar 31, 2024 | 15.03 Mn |
| Dec 31, 2023 | 15.10 Mn |
| Sep 30, 2023 | 15.14 Mn |
| Jun 30, 2023 | 15.20 Mn |
| Mar 31, 2023 | 15.10 Mn |
| Dec 31, 2022 | 15.17 Mn |
| Sep 30, 2022 | 25.24 Mn |
| Jun 30, 2022 | 15.28 Mn |
| Mar 31, 2022 | 15.34 Mn |
| Dec 31, 2021 | 15.40 Mn |
| Sep 30, 2021 | 15.46 Mn |
| Jun 30, 2021 | 14.77 Mn |
| Mar 31, 2021 | 14.63 Mn |